Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2014-03-20
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate BLISTER — outcome: RECOVERED/RESOLVED; onset 2014-07-09 (study day 112.0); relationship: PROBABLE
severe
assessed
2026-08-18
Severe BLISTER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-08-17 (study day 151.0); relationship: PROBABLE
severe
assessed
2026-08-18
Severe BLISTER — outcome: RECOVERED/RESOLVED; onset 2014-08-17 (study day 151.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-09 (study day 112.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-09 (study day 112.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.